DE60325904D1 - COSMETIC AND / OR PHARMACEUTICAL PREPARATION FOR THE TREATMENT AND PREVENTION OF IRRITATION, IGNITION AND HAUTERYTHEMA - Google Patents
COSMETIC AND / OR PHARMACEUTICAL PREPARATION FOR THE TREATMENT AND PREVENTION OF IRRITATION, IGNITION AND HAUTERYTHEMAInfo
- Publication number
- DE60325904D1 DE60325904D1 DE60325904T DE60325904T DE60325904D1 DE 60325904 D1 DE60325904 D1 DE 60325904D1 DE 60325904 T DE60325904 T DE 60325904T DE 60325904 T DE60325904 T DE 60325904T DE 60325904 D1 DE60325904 D1 DE 60325904D1
- Authority
- DE
- Germany
- Prior art keywords
- cosmetic
- agents
- induced
- radiation
- irritation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title abstract 3
- 230000007794 irritation Effects 0.000 title abstract 3
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000005855 radiation Effects 0.000 abstract 5
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000013043 chemical agent Substances 0.000 abstract 1
- 239000008406 cosmetic ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The present invention has as subject a new composition for cosmetic or pharmaceutical use intended for external use to be applied both to undamaged and damaged skin or onto the mucosa to reduce or inhibit irritation, inflammation and cutaneous erythemia induced by events of an exogenous nature (irritations induced by chemical agents, pharmaceuticals, cosmetic ingredients, physical agents-such as, for example, solar radiation, ultraviolet radiation, ionising radiation, X rays, gamma rays, laser light-bacterial agents, viral agents, etc) and to photoprotect the skin from solar radiation and specifically from damage induced by ultraviolet radiation of types A, B and C. More particularly, the present invention refers to the use of dimethyl sulphone in the preparation of a pharmaceutical or cosmetic composition for topical use, to prevent and/or cure the above mentioned cutaneous manifestations.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2003/000340 WO2004105741A1 (en) | 2003-05-30 | 2003-05-30 | Cosmetic and/or pharmaceutical compositions comprising dimthylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60325904D1 true DE60325904D1 (en) | 2009-03-05 |
Family
ID=33485485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60325904T Expired - Lifetime DE60325904D1 (en) | 2003-05-30 | 2003-05-30 | COSMETIC AND / OR PHARMACEUTICAL PREPARATION FOR THE TREATMENT AND PREVENTION OF IRRITATION, IGNITION AND HAUTERYTHEMA |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070009451A1 (en) |
EP (1) | EP1641443B1 (en) |
JP (1) | JP2006525951A (en) |
CN (1) | CN1771028A (en) |
AT (1) | ATE420631T1 (en) |
AU (1) | AU2003238687B8 (en) |
CA (1) | CA2525692A1 (en) |
DE (1) | DE60325904D1 (en) |
ES (1) | ES2322345T3 (en) |
HR (1) | HRPK20050965B3 (en) |
TW (1) | TW200500059A (en) |
WO (1) | WO2004105741A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1631248A1 (en) * | 2003-05-30 | 2006-03-08 | Gianfranco De Paoli Ambrosi | A formulation for chemical peeling |
ITBS20040068A1 (en) * | 2004-05-24 | 2004-08-24 | Gen Topics Srl | COSMETIC AND / OR PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ROSACEA |
EP1932524A1 (en) * | 2006-12-13 | 2008-06-18 | Ludwig-Maximilians-Universität München | Pharmaceutical preparations for treating inflammatory diseases |
JP2008291032A (en) * | 2008-06-04 | 2008-12-04 | Paoli Ambrosi Gianfranco De | Prescription for chemical peeling |
JP5753089B2 (en) * | 2008-10-20 | 2015-07-22 | ドウ ファーマシューティカル サイエンシーズ、インク. | Method for obtaining a stable dispersion of benzoyl peroxide |
ITBS20120093A1 (en) * | 2012-06-04 | 2013-12-05 | Paoli Ambrosi Gianfranco De | COSMETIC AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF SKIN INFLAMMATION AND RELATED SYNDROMES |
BR112020020541A2 (en) * | 2018-04-09 | 2021-01-12 | Noon Aesthetics M.R Ltd. | TOPICAL FORMULATIONS THAT UNDERSTAND STRENGTH AND METHYLPHONYL METHANE (MSM) AND TREATMENT METHODS |
KR20210122552A (en) * | 2020-04-01 | 2021-10-12 | (주)아모레퍼시픽 | Additive composition comprising pyruvate for preventing oxidation of Vitamin C |
WO2023177625A1 (en) * | 2022-03-14 | 2023-09-21 | Blue Hill Technologies Llc | Shelf-stable formulations of benzoyl peroxide and methods of producing same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4974793A (en) * | 1992-09-04 | 1994-03-29 | Aws Shakir Mustafa Salim | Skin treatment compositions containing dimethylsulphone and dimethylsulphoxide |
AU4974693A (en) * | 1992-09-04 | 1994-03-29 | Aws Shakir Mustafa Salim | Dermatological treatment compositions containing dimethylsulphone and a sulfur containing amino acid |
AU4974893A (en) * | 1992-09-04 | 1994-03-29 | Aws Shakir Mustafa Salim | Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol |
GB9218701D0 (en) * | 1992-09-04 | 1992-10-21 | Salim Aws S M | Housewife dermatitis treatment |
US6399093B1 (en) * | 1999-05-19 | 2002-06-04 | Advanced Medical Instruments | Method and composition to treat musculoskeletal disorders |
US6653352B2 (en) * | 1999-09-29 | 2003-11-25 | Medical Merchandising, Inc. | Pain reliever and method of use |
US6328987B1 (en) * | 2000-11-03 | 2001-12-11 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions containing alpha interferon |
NL1017333C2 (en) * | 2001-02-12 | 2002-08-13 | Gent Natural Products Van | Cosmetic resp. pharmaceutical preparation. |
ITBS20040068A1 (en) * | 2004-05-24 | 2004-08-24 | Gen Topics Srl | COSMETIC AND / OR PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ROSACEA |
-
2003
- 2003-05-30 ES ES03733017T patent/ES2322345T3/en not_active Expired - Lifetime
- 2003-05-30 US US10/557,925 patent/US20070009451A1/en not_active Abandoned
- 2003-05-30 AT AT03733017T patent/ATE420631T1/en not_active IP Right Cessation
- 2003-05-30 CN CNA038265672A patent/CN1771028A/en active Pending
- 2003-05-30 AU AU2003238687A patent/AU2003238687B8/en not_active Ceased
- 2003-05-30 DE DE60325904T patent/DE60325904D1/en not_active Expired - Lifetime
- 2003-05-30 EP EP03733017A patent/EP1641443B1/en not_active Expired - Lifetime
- 2003-05-30 CA CA002525692A patent/CA2525692A1/en not_active Abandoned
- 2003-05-30 JP JP2005500190A patent/JP2006525951A/en active Pending
- 2003-05-30 WO PCT/IT2003/000340 patent/WO2004105741A1/en active Application Filing
-
2004
- 2004-05-20 TW TW093114249A patent/TW200500059A/en unknown
-
2005
- 2005-11-18 HR HR20050965A patent/HRPK20050965B3/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2006525951A (en) | 2006-11-16 |
AU2003238687A1 (en) | 2005-01-21 |
CN1771028A (en) | 2006-05-10 |
CA2525692A1 (en) | 2004-12-09 |
ES2322345T3 (en) | 2009-06-19 |
AU2003238687B2 (en) | 2009-07-02 |
ATE420631T1 (en) | 2009-01-15 |
US20070009451A1 (en) | 2007-01-11 |
EP1641443A1 (en) | 2006-04-05 |
EP1641443B1 (en) | 2009-01-14 |
WO2004105741A1 (en) | 2004-12-09 |
HRPK20050965B3 (en) | 2007-11-30 |
AU2003238687B8 (en) | 2009-08-06 |
TW200500059A (en) | 2005-01-01 |
HRP20050965A2 (en) | 2006-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRPK20050965B3 (en) | Cosmetic and/or pharmaceutical compositions comprising dimethylsulphone for the cure and prevention of irritation, inflammation and cutaneous erythema | |
DE60027463D1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING RESVERATROL AND USES THEREOF | |
BR112015012565A2 (en) | compound, cosmetic or pharmaceutical composition, and use of a compound | |
ATE361084T1 (en) | TOPICAL PHARMACEUTICAL COMPOSITIONS CONTAINING PROANTHOCYANIDINS, GLYCYRRHETINIC ACID AND TELMESTEINS FOR THE TREATMENT OF DERMATITIS | |
DE69532751D1 (en) | Cosmetic, pharmaceutical or dermatological composition, as well as the composition containing alpha TNF antagonists | |
AR047513A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CHANGES IN THE SKIN RELATED TO AGING AND DAMAGES CAUSED BY THE ENVIRONMENT | |
YU7296A (en) | Novel pharmaceutical combination containing antivirus substance and one anti-inflamatory glucocorticoid | |
DK1797053T3 (en) | Phenothiazinium compound for wound healing | |
CY1108932T1 (en) | Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases | |
BR0308429A (en) | Monocyclic Aroylpyridinones as Anti-Inflammatory Agents | |
ES2188963T3 (en) | USE OF GENISTEINE AS A PREVENTION AGAINST PHOTOLESION AND SKIN CANCER INDUCED BY ULTRAVIOLET RADIATION. | |
DE602004011374D1 (en) | TRANSDERMALE PHARMACEUTICAL COMPOSITION | |
BR0315580A (en) | Methylene Urea Derivatives | |
EP0382066A3 (en) | Use of dihydroliponic acid as an analgetic, antiphlogistic and/or cytoprotective agent | |
ATE287267T1 (en) | COMBINATION THERAPIES WITH VASCULAR DAMAGE ACTIVITY | |
DE69939720D1 (en) | Fulvic acid and its use in the treatment of viral infections | |
DE3681647D1 (en) | PREPARATION WITH EFFECT AGAINST ACNE AND USE OF ACTIVE SUBSTANCE EXTRACT OF MERCURY WHEAT. | |
DE112004000961D2 (en) | Use of active substances for the prevention or treatment of viral diseases and test system for finding such active substances | |
NO20073575L (en) | Pharmaceutical compositions for the treatment of cellulite | |
BR0007452A (en) | Use of melagatran or a pharmaceutically acceptable derivative or prodrug thereof, method of treating inflammation, and, pharmaceutical formulation for use in treating inflammation | |
KR20150090920A (en) | Methods for preventing and treating inflammatory skin conditions | |
Jagetia et al. | Mimosa pudica (Lajwanti) accelerates repair and regeneration of deep dermal excision wound in Swiss albino mice | |
ATE375163T1 (en) | COMPOSITIONS CONTAINING VERNIX AND A UV PROTECTIVE AGENT AND THE USE THEREOF | |
ES2915824T3 (en) | Antiviral pharmaceutical composition for topical use | |
EP0182881A1 (en) | Topical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |